Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory follicles
- PMID: 8288744
- DOI: 10.1093/oxfordjournals.humrep.a137941
Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory follicles
Abstract
The effects of recombinant human follicle stimulating hormone (rFSH; Org 32489) have been examined in human granulosa cells from ovaries obtained from women with spontaneous menses. In the first series of experiments the actions of rFSH on production of oestradiol and progesterone were compared with those of urinary-derived gonadotrophins. Recombinant FSH induced dose-dependent increases in production of both oestradiol and progesterone which were similar to the effects of 'pure' FSH (Metrodin) and the International Standard IS 71/223. In further studies, the actions of rFSH on oestradiol production by individual preovulatory follicles were investigated; rFSH increased oestradiol accumulation from cells obtained from follicles before the luteinizing hormone (LH) surge. In contrast, rFSH inhibited oestradiol production by granulosa cells derived from a follicle after the onset of the LH surge, whereas the gonadotrophic action of growth hormone was maintained. Following preliminary reports of the in-vivo effects of rFSH in women, these findings provide further validation of the efficacy of rFSH in the human ovary. The results of studies of the preovulatory follicle illustrate the experimental importance of the availability of recombinant preparations of pure gonadotrophins, produced by recombinant technology, in the understanding of human ovarian function.
Comment in
-
The clinical benefits of recombinant gonadotrophins.Hum Reprod. 2000 Mar;15(3):734-5. doi: 10.1093/humrep/15.3.734. Hum Reprod. 2000. PMID: 10686229 No abstract available.
Similar articles
-
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).Hum Reprod. 1996 May;11(5):962-7. doi: 10.1093/oxfordjournals.humrep.a019332. Hum Reprod. 1996. PMID: 8671371 Clinical Trial.
-
Differential responses of granulosa cells from small and large follicles to follicle stimulating hormone (FSH) during the menstrual cycle and acyclicity: effects of tumour necrosis factor-alpha.Hum Reprod. 1998 May;13(5):1285-91. doi: 10.1093/humrep/13.5.1285. Hum Reprod. 1998. PMID: 9647561
-
Recombinant human gonadotropins stimulate steroid and inhibin production in human granulosa cells.Eur J Endocrinol. 1997 Jun;136(6):617-23. doi: 10.1530/eje.0.1360617. Eur J Endocrinol. 1997. PMID: 9225725
-
Basic physiology of follicular maturation in the pig.J Reprod Fertil Suppl. 1985;33:1-19. J Reprod Fertil Suppl. 1985. PMID: 3003359 Review.
-
Developments in human recombinant follicle stimulating hormone technology: are we going in the right direction?Hum Reprod. 1998 Jun;13 Suppl 3:36-46; discussion 47-51. doi: 10.1093/humrep/13.suppl_3.36. Hum Reprod. 1998. PMID: 9755413 Review.
Cited by
-
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.J Assist Reprod Genet. 1998 Oct;15(9):552-9. doi: 10.1023/a:1022586221077. J Assist Reprod Genet. 1998. PMID: 9822984 Free PMC article.
-
Herbimycin, a tyrosine kinase inhibitor with Src selectivity, reduces progesterone and estradiol secretion by human granulosa cells.Endocrine. 2001 Aug;15(3):271-6. doi: 10.1385/ENDO:15:3:271. Endocrine. 2001. PMID: 11762698
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources